Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) requiring chiral piperazine scaffolds. Its protected amine group allows for selective reactions in multi-step organic syntheses. Commonly employed in the production of drugs targeting central nervous system disorders, metabolic diseases, and infectious diseases due to the piperazine ring’s favorable pharmacokinetic properties. Also utilized in research settings for building blocks in medicinal chemistry and library synthesis for drug discovery.